BioNTech SE — Form D
BioNTech SE of MAINZ, 2M, a company, filed a Form D exempt-offering notice with the SEC on 2020-09-17. The offering totals $250.0M, of which $250.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-09-17
- Form: D
- Accession: 0001209191-20-050787
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $250.0M
- Amount sold: $250.0M
- Investors: 2
- Date of first sale: 2020-09-07
- Security types: equity, debt
- Revenue range: Over $100,000,000
- SEC file number: 021-375736
Issuer
- Name: BioNTech SE
- CIK: 0001776985
- Entity type: Corporation
- Jurisdiction: GERMANY
- Address: AN DER GOLDGRUBE 12, MAINZ, 2M, D-55131
- Phone: 49 6131-9084-0
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Sean Marett | Executive Officer | Boston, MA |
| Helmut Jeggle | Director | Boston, MA |
| Ryan Richardson | Executive Officer | Scottsdale, AZ |
| Ugur Sahin | Executive Officer | MAINZ, 2M |
| Michael Motschmann | Director | MAINZ, 2M |
| Sierk Poetting | Executive Officer | MAINZ, 2M |
| Christoph Huber | Director | MAINZ, 2M |
| Jens Holstein | Executive Officer | MAINZ, 2M |
| Ozlem Tureci | Executive Officer | MAINZ, 2M |
| Ulrich Wandschneider | Director | MAINZ, 2M |
Other filings by this issuer (1)
More